Published in Mol Microbiol on December 19, 2012
Defining the metabolic requirements for the growth and colonization capacity of Campylobacter jejuni. Front Cell Infect Microbiol (2014) 0.90
Campylobacter jejuni ferric-enterobactin receptor CfrA is TonB3 dependent and mediates iron acquisition from structurally different catechol siderophores. Metallomics (2013) 0.85
Specific TonB-ExbB-ExbD energy transduction systems required for ferric enterobactin acquisition in Campylobacter. FEMS Microbiol Lett (2013) 0.84
Gene Loss and Lineage-Specific Restriction-Modification Systems Associated with Niche Differentiation in the Campylobacter jejuni Sequence Type 403 Clonal Complex. Appl Environ Microbiol (2015) 0.79
Bacteria in an intense competition for iron: Key component of the Campylobacter jejuni iron uptake system scavenges enterobactin hydrolysis product. Proc Natl Acad Sci U S A (2016) 0.79
Survival with a Helping Hand: Campylobacter and Microbiota. Front Microbiol (2015) 0.78
Adhesion, Biofilm Formation, and Genomic Features of Campylobacter jejuni Bf, an Atypical Strain Able to Grow under Aerobic Conditions. Front Microbiol (2016) 0.77
Important Role of a Putative Lytic Transglycosylase Cj0843c in β-Lactam Resistance in Campylobacter jejuni. Front Microbiol (2015) 0.75
Interactions of the periplasmic binding protein CeuE with Fe(III) n-LICAM(4-) siderophore analogues of varied linker length. Sci Rep (2017) 0.75
The RAST Server: rapid annotations using subsystems technology. BMC Genomics (2008) 175.18
Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res (2004) 28.63
The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature (2000) 17.14
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature (2004) 9.40
Reordering contigs of draft genomes using the Mauve aligner. Bioinformatics (2009) 6.97
Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med (1995) 5.73
Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species. PLoS Biol (2005) 5.22
Unique features of a highly pathogenic Campylobacter jejuni strain. Infect Immun (2006) 5.21
Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev (2007) 4.87
Enterochelin system of iron transport in Escherichia coli: mutations affecting ferric-enterochelin esterase. J Bacteriol (1972) 4.45
Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe (2009) 4.20
Next-generation sequencing: from basic research to diagnostics. Clin Chem (2009) 4.18
Enterobactin: an archetype for microbial iron transport. Proc Natl Acad Sci U S A (2003) 3.94
Chloramphenicol resistance in Campylobacter coli: nucleotide sequence, expression, and cloning vector construction. Gene (1990) 3.67
Construction of new Campylobacter cloning vectors and a new mutational cat cassette. Gene (1993) 3.61
xBASE2: a comprehensive resource for comparative bacterial genomics. Nucleic Acids Res (2007) 3.35
CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob Agents Chemother (2002) 3.31
Enterochelin hydrolysis and iron metabolism in Escherichia coli. Biochim Biophys Acta (1971) 2.78
Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc Natl Acad Sci U S A (2003) 2.56
Identification of a new iron regulated locus of Salmonella typhi. Gene (1996) 2.46
Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun (2003) 2.09
Iron acquisition and regulation in Campylobacter jejuni. J Bacteriol (2004) 1.98
CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni. Antimicrob Agents Chemother (2005) 1.83
A new class of cleavable fluorescent nucleotides: synthesis and optimization as reversible terminators for DNA sequencing by synthesis. Nucleic Acids Res (2008) 1.82
Campylobacter jejuni gene expression in response to iron limitation and the role of Fur. Microbiology (2005) 1.67
Evolutionary dynamics of complete Campylobacter pan-genomes and the bacterial species concept. Genome Biol Evol (2010) 1.54
Iron acquisition and hemolysin production by Campylobacter jejuni. Infect Immun (1992) 1.54
Major role for FeoB in Campylobacter jejuni ferrous iron acquisition, gut colonization, and intracellular survival. Infect Immun (2006) 1.52
Export of the siderophore enterobactin in Escherichia coli: involvement of a 43 kDa membrane exporter. Mol Microbiol (2002) 1.49
Overexpression and purification of ferric enterobactin esterase from Escherichia coli. Demonstration of enzymatic hydrolysis of enterobactin and its iron complex. J Biol Chem (1992) 1.47
In vitro characterization of salmochelin and enterobactin trilactone hydrolases IroD, IroE, and Fes. J Am Chem Soc (2005) 1.47
Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J Antimicrob Chemother (2005) 1.42
Influence of iron on growth, morphology, outer membrane protein composition, and synthesis of siderophores in Campylobacter jejuni. Infect Immun (1986) 1.37
Enterochelin acquisition in Campylobacter coli: characterization of components of a binding-protein-dependent transport system. Microbiology (1995) 1.33
Specific roles of the iroBCDEN genes in virulence of an avian pathogenic Escherichia coli O78 strain and in production of salmochelins. Infect Immun (2008) 1.26
Functions of the siderophore esterases IroD and IroE in iron-salmochelin utilization. Microbiology (2005) 1.20
New enzymes involved in aerobic benzoate metabolism in Azoarcus evansii. Mol Microbiol (2004) 1.15
Competing isogenic Campylobacter strains exhibit variable population structures in vivo. Appl Environ Microbiol (2008) 1.03
Pumping iron: mechanisms for iron uptake by Campylobacter. Microbiology (2009) 1.03
Identification and characterization of a new ferric enterobactin receptor, CfrB, in Campylobacter. J Bacteriol (2010) 0.98
Contribution of CmeG to antibiotic and oxidative stress resistance in Campylobacter jejuni. J Antimicrob Chemother (2010) 0.97
The BfeR regulator mediates enterobactin-inducible expression of Bordetella enterobactin utilization genes. J Bacteriol (2004) 0.97
Structural characterization of enterobactin hydrolase IroE. Biochemistry (2006) 0.96
Molecular, antigenic, and functional characteristics of ferric enterobactin receptor CfrA in Campylobacter jejuni. Infect Immun (2009) 0.95
Riboflavin biosynthesis is associated with assimilatory ferric reduction and iron acquisition by Campylobacter jejuni. Appl Environ Microbiol (2007) 0.95
Utilization of lactoferrin-bound and transferrin-bound iron by Campylobacter jejuni. J Bacteriol (2008) 0.95
Ferredoxin-NADP+ reductase from Pseudomonas putida functions as a ferric reductase. J Bacteriol (2008) 0.93
The siderophore-interacting protein YqjH acts as a ferric reductase in different iron assimilation pathways of Escherichia coli. Biochemistry (2011) 0.90
Escherichia coli ferredoxin-NADP+ reductase and oxygen-insensitive nitroreductase are capable of functioning as ferric reductase and of driving the Fenton reaction. Biometals (2010) 0.82
Improving the maternal mortality ratio in Zhejiang Province, China, 1988-2008. Midwifery (2010) 2.04
Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc Natl Acad Sci U S A (2005) 2.04
Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer. Breast Cancer Res Treat (2012) 1.71
In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob Agents Chemother (2003) 1.71
WRKY transcription factors: key components in abscisic acid signalling. Plant Biotechnol J (2011) 1.57
Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev (2012) 1.54
Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J Antimicrob Chemother (2005) 1.42
Role of mast cells in acupuncture effect: a pilot study. Explore (NY) (2008) 1.32
Recent progress in rare earth micro/nanocrystals: soft chemical synthesis, luminescent properties, and biomedical applications. Chem Rev (2013) 1.29
MicroRNA-181a modulates gene expression of zinc finger family members by directly targeting their coding regions. Nucleic Acids Res (2010) 1.29
CmeR functions as a pleiotropic regulator and is required for optimal colonization of Campylobacter jejuni in vivo. J Bacteriol (2008) 1.24
N'-(4-Diethyl-amino-2-hy-droxy-benzyl-idene)-4-(dimethyl-amino)-benzo-hydrazide methanol monosolvate. Acta Crystallogr Sect E Struct Rep Online (2011) 1.22
miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J (2013) 1.22
Self-assembled alluaudite Na(2)Fe(3-x)Mn(x)(PO4)(3) micro/nanocompounds for sodium-ion battery electrodes: a new insight into their electronic and geometric structure. Chemistry (2014) 1.22
Photocatalytic activity, antibacterial effect, and photoinduced hydrophilicity of TiO2 films coated on a stainless steel substrate. Environ Sci Technol (2003) 1.20
Evaluation of the antioxidant effects of carotenoids from Deinococcus radiodurans through targeted mutagenesis, chemiluminescence, and DNA damage analyses. Biochim Biophys Acta (2007) 1.17
Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure. J Antimicrob Chemother (2006) 1.16
A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier. Biomaterials (2009) 1.14
Two isotypic transition metal germanophosphates M(II)4(H2O)4[Ge(OH)2(HPO4)2(PO4)2] (M(II) = Fe, Co): synthesis, structure, Mössbauer spectroscopy, and magnetic properties. Inorg Chem (2012) 1.12
Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ Res (2010) 1.12
Preparation and photocatalytic behavior of MoS2 and WS2 nanocluster sensitized TiO2. Langmuir (2004) 1.12
In vivo multimodality imaging and cancer therapy by near-infrared light-triggered trans-platinum pro-drug-conjugated upconverison nanoparticles. J Am Chem Soc (2013) 1.10
Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway. Cell Signal (2011) 1.10
Analysis of RF heating and sample stability in aligned static solid-state NMR spectroscopy. J Magn Reson (2006) 1.10
Methotrexate therapy for cesarean section scar pregnancy with and without suction curettage. Fertil Steril (2008) 1.07
Direct sonochemical preparation of high-surface-area nanoporous ceria and ceria-zirconia solid solutions. J Colloid Interface Sci (2003) 1.06
Sensing and modulation of invadopodia across a wide range of rigidities. Biophys J (2011) 1.05
Up-conversion cell imaging and pH-induced thermally controlled drug release from NaYF4/Yb3+/Er3+@hydrogel core-shell hybrid microspheres. ACS Nano (2012) 1.05
Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode. Bioorg Med Chem (2009) 1.03
Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrob Agents Chemother (2008) 1.02
Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats. Eur J Pharmacol (2008) 1.01
Defect-related luminescent materials: synthesis, emission properties and applications. Chem Soc Rev (2012) 1.01
Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria. Front Microbiol (2013) 1.01
Magnetic Fe3O4@mesoporous silica composites for drug delivery and bioadsorption. J Colloid Interface Sci (2012) 1.01
Tunable luminescence and energy transfer properties of Sr₃AlO₄F:RE³+ (RE = Tm/Tb, Eu, Ce) phosphors. ACS Appl Mater Interfaces (2011) 1.00
Highly uniform and monodisperse beta-NaYF(4):Ln(3+) (Ln = Eu, Tb, Yb/Er, and Yb/Tm) hexagonal microprism crystals: hydrothermal synthesis and luminescent properties. Inorg Chem (2007) 1.00
A yolk-like multifunctional platform for multimodal imaging and synergistic therapy triggered by a single near-infrared light. ACS Nano (2015) 0.99
Anesthetic aspect of malaria disease: a brief review. Middle East J Anaesthesiol (2012) 0.99
Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts. Eur J Pharmacol (2009) 0.99
Identification and characterization of a new ferric enterobactin receptor, CfrB, in Campylobacter. J Bacteriol (2010) 0.98
Uniform colloidal alkaline earth metal fluoride nanocrystals: nonhydrolytic synthesis and luminescence properties. Inorg Chem (2008) 0.97
Monodisperse and core-shell-structured SiO2@YBO3:Eu3+ spherical particles: synthesis and characterization. Inorg Chem (2007) 0.97
Radioactivity concentrations in soils of the Xiazhuang granite area, China. Appl Radiat Isot (2005) 0.97
Current advances in lanthanide ion (Ln(3+))-based upconversion nanomaterials for drug delivery. Chem Soc Rev (2015) 0.96
Toward the design of novel polynuclear platinum antitumor complexes: a polydentate ligand system based on dipyridylamine and 1,3,5-trimethylenebenzene. Inorg Chem (2003) 0.96
Fabrication and luminescence properties of one-dimensional CaMoO(4): Ln(3+) (Ln = Eu, Tb, Dy) nanofibers via electrospinning process. Langmuir (2009) 0.96
Molecular, antigenic, and functional characteristics of ferric enterobactin receptor CfrA in Campylobacter jejuni. Infect Immun (2009) 0.95
In situ preparation and luminescent properties of LaPO4:Ce3+, Tb3+ nanoparticles and transparent LaPO4:Ce3+, Tb3+/PMMA nanocomposite. J Colloid Interface Sci (2009) 0.95
Dehydration-induced WRKY genes from tobacco and soybean respond to jasmonic acid treatments in BY-2 cell culture. Biochem Biophys Res Commun (2013) 0.95
Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China. Eur J Pediatr (2013) 0.94
Synthesis and characterization of high-quality ZnS, ZnS:Mn2+, and ZnS:Mn2+/ZnS (core/shell) luminescent nanocrystals. Inorg Chem (2007) 0.94
Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system. Inorg Chem (2007) 0.94
The possible role of the Akt signaling pathway in schizophrenia. Brain Res (2012) 0.94
Accurate preoperative staging of gastric cancer with combined endoscopic ultrasonography and PET-CT. Tohoku J Exp Med (2012) 0.93
Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier. Biomaterials (2008) 0.93
Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies. J Minim Invasive Gynecol (2010) 0.93
3,9-Di-2-furyl-2,4,8,10-tetra-oxa-spiro-[5.5]undecane. Acta Crystallogr Sect E Struct Rep Online (2008) 0.93
Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. J Card Fail (2007) 0.93
An ERK-p38 subnetwork coordinates host cell apoptosis and necrosis during coxsackievirus B3 infection. Cell Host Microbe (2013) 0.92
Functional cloning and characterization of antibiotic resistance genes from the chicken gut microbiome. Appl Environ Microbiol (2012) 0.91
Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma. Med Oncol (2010) 0.91
The effects of anesthetics on tumor progression. Int J Physiol Pathophysiol Pharmacol (2013) 0.91
1-(2,6-Difluoro-benzo-yl)-3-(2,3,5-tri-chloro-phen-yl)urea. Acta Crystallogr Sect E Struct Rep Online (2008) 0.90
Innervation of endometrium and myometrium in women with painful adenomyosis and uterine fibroids. Fertil Steril (2009) 0.90
Characterization of NocL involved in thiopeptide nocathiacin I biosynthesis: a [4Fe-4S] cluster and the catalysis of a radical S-adenosylmethionine enzyme. J Biol Chem (2011) 0.90
Bluish-white emission from radical carbonyl impurities in amorphous Al(2)O(3) prepared via the Pechini-type sol-gel process. Inorg Chem (2007) 0.90
Apigenin protects endothelium-dependent relaxation of rat aorta against oxidative stress. Eur J Pharmacol (2009) 0.90
Role of inducible nitric oxide synthase expression in aberrant crypt foci-adenoma-carcinoma sequence. World J Gastroenterol (2003) 0.89
Uniform hollow Lu2O3:Ln (Ln = Eu3+, Tb3+) spheres: facile synthesis and luminescent properties. Inorg Chem (2011) 0.89
Rattle-type hollow CaWO4:Tb(3+)@SiO2 nanocapsules as carriers for drug delivery. Dalton Trans (2011) 0.89
Monofunctional platinum complexes showing potent cytotoxicity against human liver carcinoma cell line BEL-7402. J Med Chem (2003) 0.89
Recent progress in low-voltage cathodoluminescent materials: synthesis, improvement and emission properties. Chem Soc Rev (2014) 0.89
Role of collagen fibers in acupuncture analgesia therapy on rats. Connect Tissue Res (2009) 0.88
Poly(acrylic acid) modified lanthanide-doped GdVO4 hollow spheres for up-conversion cell imaging, MRI and pH-dependent drug release. Nanoscale (2012) 0.88
Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery. Small (2013) 0.88
Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome. J Pharm Pharmacol (2009) 0.88
Hollow structured upconversion luminescent NaYF₄:Yb³⁺, Er³⁺ nanospheres for cell imaging and targeted anti-cancer drug delivery. Biomaterials (2012) 0.88
Identification of putative virulence-associated genes of Haemophilus parasuis through suppression subtractive hybridization. Vet Microbiol (2010) 0.87
Solvothermal synthesis of well-dispersed MF(2) (M = Ca,Sr,Ba) nanocrystals and their optical properties. Nanotechnology (2008) 0.87
Effect of an efflux pump inhibitor on the function of the multidrug efflux pump CmeABC and antimicrobial resistance in Campylobacter. Foodborne Pathog Dis (2006) 0.87
Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems. Biomaterials (2007) 0.87
Identification and characterization of a bile salt hydrolase from Lactobacillus salivarius for development of novel alternatives to antibiotic growth promoters. Appl Environ Microbiol (2012) 0.87
Local anesthetic lidocaine inhibits TRPM7 current and TRPM7-mediated zinc toxicity. CNS Neurosci Ther (2014) 0.86
Prevalence, development, and molecular mechanisms of bacteriocin resistance in Campylobacter. Appl Environ Microbiol (2011) 0.86
Shape-controllable synthesis and morphology-dependent luminescence properties of GaOOH:Dy(3+) and beta-Ga(2)O(3):Dy(3+). Inorg Chem (2010) 0.86
Conscious sedation and anesthesia in the cardiac electrophysiology laboratory. J Cardiovasc Electrophysiol (2012) 0.86
Endometrial nerve fibers in women with endometriosis, adenomyosis, and uterine fibroids. Fertil Steril (2009) 0.86
Single large cystic adenomyoma of the uterus after cornual pregnancy and curettage. Fertil Steril (2007) 0.85
Identification and functional analysis of a phytoene desaturase gene from the extremely radioresistant bacterium Deinococcus radiodurans. Microbiology (2007) 0.85
Subunit and frequency-dependent inhibition of acid sensing ion channels by local anesthetic tetracaine. Mol Pain (2013) 0.85
Hysteroscopic septum resection of complete septate uterus with cervical duplication, sparing the double cervix in patients with recurrent spontaneous abortions or infertility. Fertil Steril (2008) 0.85
IKK interacts with rictor and regulates mTORC2. Cell Signal (2013) 0.85
Light-induced cell detachment for cell sheet technology. Biomaterials (2012) 0.85
Expression of angiopoietin-2 is correlated with vascularization and tumor size in human colorectal adenocarcinoma. Tohoku J Exp Med (2007) 0.84
Modification of chitosan membrane with poly(vinyl alcohol) and biocompatibility evaluation. Int J Biol Macromol (2012) 0.84
mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo. Breast Cancer Res Treat (2012) 0.84